phrykt

Lakefront Biotherapeutics NV (LKFT): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of LKFT were reported in the last 12 months. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Lakefront Biotherapeutics NV

From the latest filings

Overall: about as much buying as selling. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns LKFT

77 funds and institutions reported LKFT shares worth $960M at the end of Q2 2026, about 49% of the company. The largest holder is Gilead Sciences, Inc. with 25.4%.

Funds and institutions (13F) 49%Everyone else 51%

10 largest owners, by share of the company

Gilead Sciences, Inc.25.4%
Tang Capital Management LLC5.7%
Madison Avenue Partners, LP5.2%
Prosight Management, LP3.1%
EcoR1 Capital, LLC2.5%
Ameriprise Financial Inc1.9%
DME Capital Management, LP0.7%
Renaissance Technologies LLC0.6%
BlackRock, Inc.0.5%
Point72 Asset Management, L.P.0.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Gilead Sciences, Inc.16.71M25.35%$500MNo change
Tang Capital Management LLC3.79M5.75%$114MNo change
Madison Avenue Partners, LP3.45M5.23%$103M+40%
Prosight Management, LP2.04M3.10%$61.3M+32%
EcoR1 Capital, LLC1.67M2.53%$50MNo change
Ameriprise Financial Inc1.27M1.93%$38.1M-11%
DME Capital Management, LP482,7460.73%$14.5MNo change
Renaissance Technologies LLC407,8000.62%$12.2M+29%
BlackRock, Inc.338,1520.51%$10.1M+8%
Point72 Asset Management, L.P.269,8140.41%$8.1M-19%
D. E. Shaw & Co., Inc.197,8440.30%$5.9M-8%
Millennium Management LLC181,0900.27%$5.4M+68%
UBS Group AG168,1480.26%$5M-4%
Susquehanna International Group, LLP151,8860.23%$4.6M+1035%
DAFNA Capital Management LLC130,1750.20%$3.9MNo change
Citadel Advisors LLC88,3430.13%$2.6M-29%
Two Sigma Investments, LP81,7490.12%$2.5M+216%
Norges Bank76,8790.12%$2.3MNew
Alps Advisors Inc65,5230.10%$2M+22%
Goldman Sachs Group Inc56,5810.09%$1.7M+25%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

No LKFT insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

LKFT short interest

1.30M LKFT shares are sold short. Over the last 12 reports the number of shares short went down 19%.

As of Oct 30, 2026, 1.30M LKFT shares were sold short, down 8.2% from the report before. At the average daily volume of 217,859 shares, buying them all back would take about 6.0 trading days (days to cover).

Shares short, % of all shares

3.53%May 15Jul 153.69%

Days to cover

6.0May 15Oct 3017.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.30M–-8%217,8596.0
Oct 15, 20261.42M–-57%297,0584.8
Sep 30, 20263.32M–-3%349,9659.5
Sep 15, 20263.41M–+4%276,45212.3
Aug 31, 20263.30M–+11%235,31314.0
Aug 14, 20262.97M–+18%292,33810.2
Jul 31, 20262.52M–+9%179,54414.1
Jul 15, 20262.32M3.53%+4%143,81016.1
Jun 30, 20262.24M3.40%+3%141,60315.8
Jun 15, 20262.18M3.31%+17%225,7859.7
May 29, 20261.87M2.84%+17%140,51613.3
May 15, 20261.60M2.43%+12%170,7139.4

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Famous investors that hold LKFT

5 of the 50 well-known investors we track reported holding LKFT in their latest 13F filing. The largest position is David Einhorn's, worth $14.3M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
David Einhorn · Greenlight Capital (DME)Q3 2026482,746$14.3M0.4%No change
Jim Simons · Renaissance TechnologiesQ3 2026424,700$12.6M0.0%+4%
Ken Griffin · Citadel AdvisorsQ3 2026312,634$9.3M0.0%+254%
Steve Cohen · Point72 Asset ManagementQ3 2026232,756$6.9M0.0%-14%
Israel Englander · Millennium ManagementQ3 202617,566$521K0.0%-90%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Lakefront Biotherapeutics NV (LKFT) stock

Who owns the most LKFT stock?

The largest reported owner of Lakefront Biotherapeutics NV (LKFT) is Gilead Sciences, Inc., with 25.4% of the company. In total, 77 funds and institutions reported holding LKFT at the end of Q2 2026, together about 49% of the shares. See the largest owners.

Are LKFT insiders buying or selling?

No LKFT insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in LKFT?

As of Oct 30, 2026, 1.30M LKFT shares were sold short, down 8.2% from the report before. At the average daily volume of 217,859 shares, buying them all back would take about 6.0 trading days (days to cover). See the history.

Which famous investors hold LKFT?

5 of the 50 well-known investors we track reported LKFT in their latest 13F filing, including David Einhorn, Jim Simons, Ken Griffin. The largest position is worth $14.3M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.